9th Annual Biomarkers Congress
IBCs 5th Annual China 2010 Pharmaceutical R&D Summit
Grand Hyatt Hotel

Shanghai, China
http://www.ibclifesciences.com/china/overview.xml
IBCs 5th Annual China 2010 Pharmaceutical R&D Summit

Schedule of Presentations:

Tuesday, April 6, 2010
08:30:00 Chairperson's Opening Remarks Steve Yang
08:35:00 Keynote Presentations
08:45:00 Marc Cluzel, Ph.D., M.D. Sanofi-Aventis' Strategies for 2010 and Beyond - Reorganizing and Adapting R&D for the Changing Pharmaceutical Industry Marc Cluzel
09:15:00 Piao-Yang Sun, Ph.D. From Generic Drug to New Drugs: Hengrui's Experience Piao-Yang Sun
09:20:00 Investment Panel
09:45:00 The Future of Biotechnology Investing in China Robert Nelsen
10:30:00 Morning Refreshments & Opening of Exhibit & Poster Hall
10:35:00 China R&D Leaders' Roundtable
11:00:00 China's Pharmaceutical Industry from the Insiders' Eyes Jimmy Wei, Frank Jiang, Tony Zhang, Peng Cho Tang, Li Chen, Steve Yang, Peng Wang
12:15:00 Networking Luncheon in Exhibit & Poster Hall
12:20:00 Impact of Healthcare Reform on China's Pharmaceutical Industry
13:30:00 Chairpersons' Opening Remarks Dan Zhang, Kewen Jin
13:35:00 Healthcare Reform - Moving Beyond Reading of the Tea Leaves Rajesh Parekh
14:00:00 The Progress of Essential Medicines System Reform in China: Opportunity and Challenge Shanlian Hu
14:25:00 China's Healthcare Reform: Implications for the Industrial Sectors Yuan-Li Liu
14:30:00 Panel Discussion
14:50:00 Impact of China's Healthcare Reform on the Burgeoning Industry - for MNCs, Domestic Pharma/Biotechs, Devices, Diagnostics Companies etc.
15:30:00 Concurrent Tracks I & II
15:30:00 Networking Refreshment Break with Exhibits & Poster Viewing
15:35:00 Track I: Development Strategies and Challenges of Other Emerging Markets vis-à-vis China
16:00:00 2 Chairperson's Opening Remarks Carol Zhu
16:00:00 Track II: Organizational Development and Talent Management
16:00:00 1 Chairperson's Opening Remarks Ruiping Dong
16:05:00 1 Perspectives on China vis-a-via Other Emerging Asia Markets Canwen Jiang
16:05:00 2 Compensation and Benefits in China's Pharmaceutical Industry Frank Lin
16:35:00 2 Building Innovation Culture in R&D Center Carol Zhu
16:35:00 1 Key Factors to be Considered for Clinical Development in Emerging Markets Ruiping Dong
17:00:00 2 Panel Discussion
17:05:00 2 Innovations and Best Practices in Talent Attraction, Retention and Leadership Development Lan Kang, Jennifer Jin, Carol Zhu, Elaine Lin, Frank Lin, Jerome Bucher
17:05:00 1 BioManufacturing Updates from Singapore: An Overview Steven Lee
17:30:00 Main Conference
17:35:00 1 Biotechnology Updates from India: A Focus on Innovation Vijay Chandru
18:00:00 Reception with Exhibits & Poster Viewing
19:00:00 IBC's China Pharma R&D Awards Dinner
Wednesday, April 7, 2010
07:00:00 Plenary Session
07:30:00 Featured Presentations: Public-Private Partnerships In Discovery & Development Of Unmet Medical Needs
08:50:00 Chairperson's Opening Remarks Tony Zhang
09:00:00 Robert Ridley, Ph.D. Development of Regional Innovation Networks in Asia, Africa and the Americas for R&D into Infectious Diseases Treatment and Diagnostics for Developing Countries Robert Ridley
09:30:00 Forging Triangular Partnerships in Global Healthcare - How Foundations, Academia and Industry Can Help Bring New Therapies Faster-to-Market Kanwarjit Singh
10:00:00 Networking Refreshment Break with Exhibits & Poster Viewing
10:05:00 Concurrent Tracks III & IV
10:15:00 Track III: Academic Research & Scientific Advances
10:25:00 4 Track IV: Clinical Development Strategies
10:30:00 4 Chairperson's Opening Remarks Frank Jiang
10:30:00 3 Chairperson's Opening Remarks Tony Zhang
10:35:00 4 Conducting Trials in China
10:40:00 4 Case Study: Conducting Proof-of-Concept Studies in China Karen Atkin
10:40:00 3 Functions of Structural Biology in Fundamental Research and Applications in Innovative Drug Discovery (tentative) Yigong Shi
10:45:00 4 Panel Discussion
11:10:00 3 The Strength of Drug Discovery in China: Scientific Talents and Governmental Incentives Zhen Yang
11:10:00 4 Conducting FIH Studies in China David Shao, Seymour Mong, Zhengyu Yuan, Yali Cong, Min Irwin
11:40:00 3 New Drug Candidates Discovery Based on Chemical Modification Yu-she Yang
11:45:00 3 Sponsored Presentation
12:10:00 4 Drug Safety and Post-Marketing Surveillance Junqi Zheng
12:10:00 3 MPI Research MPI Research: Leveraging Experience and Strength with Partners in China Tina Rogers
12:40:00 3 Networking Luncheon with Exhibits & Poster Viewing
12:40:00 4 Networking Luncheon with Exhibits & Poster Viewing
12:45:00 4 Clinical Development Tools: Project Management and CDM
13:00:00 4 Panel Discussion
14:00:00 4 Project Management in the New Paradigm: Global Clinical Development in Asia Barbara Zhang, Nenad Sarapa, Joanne Jiang
14:00:00 3 Neuronal Potassium Channels as Therapeutic Drug Targets for Treatment of Neuropsychiatric Disorders Kewei Wang
14:30:00 3 Novel Compounds Discovery from Natural Resources: A View of SCM (Scientific Chinese Medicine) Yi Zhun Zhu
14:35:00 3 Sponsored Presentation
15:00:00 3 Shanghai Medicilon, Inc Role of Integrated CRO in China Pharmaceutical R&D Chun-Lin Chen
15:00:00 4 Clinical Data Management in China: Opportunities and Challenges Li Ding
15:30:00 3 Networking Refreshment Break with Exhibits & Poster Viewing
15:30:00 4 Networking Refreshment Break with Exhibits & Poster Viewing
15:35:00 4 Building Clinical Development Centers in Pharmas and Academia for Global Clinical Trials
16:00:00 3 Assembly of Pharmaceutically Important Heterocycles via Copper-Catalyzed Coupling Reactions Dawei Ma
16:00:00 4 Simultaneous Global Development - What Does It Mean for China? Bradley Merchant
16:15:00 4 Panel Discussion
16:30:00 4 Building a Clinical Trial Unit in Academic Medical Centers Yangfeng Wu, Jack Xu, Frank Fan
16:30:00 3 Drug Delivery System Development in China Youxin Li
16:35:00 4 Panel Discussion
17:00:00 3 Working with the Scientific Community for Innovative Drugs Alex Zhang
17:00:00 4 Building a State-of-the-Art Clinical Development Center in China and Ensuring Efficient Site Management Ole Molsknov Beck, Paul Dai, Frank Jiang
17:30:00 3 Close of Academic Research & Scientific Advances Session
17:45:00 4 Close of Clinical Development Strategies Session
Thursday, April 8, 2010
08:00:00 Plenary Session
08:30:00 Keynote Presentations
08:50:00 Chairperson's Opening Remarks Guoliang Yu
09:00:00 Martin Mackay, Ph.D. Right Targets. Right Patients. Right Now. Martin Mackay
09:40:00 Michel Vounatsos, M.D. China: A Key Emerging Market for the New Merck Michel Vounatsos
10:10:00 Networking Refreshment Break
10:15:00 Biologics & Biosimilars Development
10:20:00 Innovative Biologics - Global Development
10:45:00 Research and Development of Next Generation of Antibody-based Therapeutics: The Challenges and Opportunities Zhenping Zhu
11:15:00 Strategy for Biologics Sigurd Okkels
11:45:00 RNAi Therapeutics in China: A Frontier for Targeted Medicine Patrick Y. Lu
12:15:00 Change of Biopharmaceutical R&D in Asia James Cai
12:45:00 Networking Luncheon
12:50:00 Innovative Biologics in China
14:00:00 A Joint Effort to Develop a Novel Anti-Cancer Antibody Drug in China Weimin Zhu, Peng Wang
14:25:00 Innovative R&D Approach for Innovative Biologics R&D in China Yingfei Wei
14:30:00 Follow-on Biologics and Bio-Betters in China
14:50:00 An MNC's Perspective on the Overall Capabilities of China's Biosimilars/FOB Development - A Comparison with US/EU Yining Zhao
15:15:00 FOB Roadmap for Bio-Pharmaceutical Industry in China Joe Zhou
15:40:00 Networking Refreshment Break
16:00:00 The SFDA's Policies and Regulations Towards Biosimilars/Bio-Betters in China Weiping Li
16:25:00 Overcoming Bottlenecks in China's Biologics Development and How Do You Bridge the Gap? Chris Chen, Joe Zhou, Yu Zhao, Guoliang Yu
17:00:00 Close of China 2010 Pharmaceutical R&D Summit
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.